Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Arata Matsuyama"'
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 34, Iss 2, Pp 867-872 (2020)
Abstract Background Dogs with sinonasal tumor can develop keratoconjunctivitis sicca (KCS) after radiation therapy (RT). In humans, the incidence of xerophtalmia is associated with the mean radiation dose received by the ipsilateral lacrimal gland (L
Externí odkaz:
https://doaj.org/article/856090b233fe402d8d085ac45f4b48a3
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0273811 (2022)
Urokinase plasminogen activator (uPA) and its receptor uPAR promote cancer invasion and metastasis and are emerging therapeutic targets in both human and canine malignancies. While their clinical significance is well-characterized in multiple human t
Externí odkaz:
https://doaj.org/article/8794e96cddc84fc3a556ec7afc4d25e8
Autor:
Arata Matsuyama, Dorothee Bienzle, Danielle Richardson, Nariman Deravi, Mei-Hua Hwang, Nikos Darzentas, Stefan M. Keller
Publikováno v:
BMC Veterinary Research, Vol 15, Iss 1, Pp 1-9 (2019)
Abstract Background Evolution of indolent to aggressive lymphoma has been described in dogs but is difficult to distinguish from the de novo development of a second, clonally distinct lymphoma. Differentiation of these scenarios can be aided by next
Externí odkaz:
https://doaj.org/article/ab1b35be2a394622a287c4b46806dc80
Autor:
Sangho, Kim, Arata, Matsuyama
Publikováno v:
Can Vet J
Autor:
Arata Matsuyama, Janet Beeler‐Marfisi, R. Darren Wood, Danielle Richardson, Jerome Calvalido, Anthony J. Mutsaers, Dorothee Bienzle
Publikováno v:
Veterinary and comparative oncologyREFERENCES.
Myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) are primary myeloid neoplasms in dogs generally considered to have a poor outcome. In this study, we assessed toxicity, efficacy and outcome of concurrent administration of doxorubicin
Autor:
Christopher J. Pinard, Samuel E. Hocker, Andrew C. Poon, Jordon M. Inkol, Arata Matsuyama, R. Darren Wood, Geoffrey A. Wood, J. Paul Woods, Anthony J. Mutsaers
Publikováno v:
Veterinary Immunology and Immunopathology. 243:110367
Urothelial carcinoma (UC) is the most common urinary tumor in dogs and despite combinational therapies, only modest improvements in survival have been achieved in recent years. Given the utility of monoclonal antibodies against PD-1 and PD-L1 in huma
Publikováno v:
Canadian Veterinary Journal / Revue Vétérinaire Canadienne; Apr2023, Vol. 64 Issue 4, p389-391, 3p
Autor:
Anthony J. Mutsaers, Arata Matsuyama
Publikováno v:
Cancer Research. 81:672-672
Introduction Human pediatric and canine osteosarcoma (OSA) are both highly metastatic primary bone cancers that share molecular and clinical similarities. Urokinase plasminogen activator (uPA) and its receptor uPAR promote invasion, metastasis and an
Autor:
Anthony J. Mutsaers, Valerie J. Poirier, Robert A. Foster, Arata Matsuyama, Fernanda B. Mantovani
Publikováno v:
Journal of the American Animal Hospital Association. 53:304-312
This retrospective study investigated the outcome of 33 dogs with splenic hemangiosarcoma treated with surgery followed by adjuvant dose-intensified doxorubicin (DOX) with or without low-dose metronomic cyclophosphamide (LDM-C) maintenance therapy. A
Autor:
Nariman Deravi, Nikos Darzentas, Mei-Hua Hwang, Stefan M. Keller, Danielle Richardson, Arata Matsuyama, Dorothee Bienzle
Publikováno v:
BMC veterinary research, vol 15, iss 1
BMC Veterinary Research
BMC Veterinary Research, Vol 15, Iss 1, Pp 1-9 (2019)
BMC Veterinary Research
BMC Veterinary Research, Vol 15, Iss 1, Pp 1-9 (2019)
Background Evolution of indolent to aggressive lymphoma has been described in dogs but is difficult to distinguish from the de novo development of a second, clonally distinct lymphoma. Differentiation of these scenarios can be aided by next generatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8fe37ea5139e01541f77306983899a
https://escholarship.org/uc/item/7p66n1qh
https://escholarship.org/uc/item/7p66n1qh